Benchmark analyst David Williams maintains Rigetti Computing (NASDAQ:RGTI) with a Buy and lowers the price target from $10 to $8.
Novo Nordisk’s Wegovy Eyes Asian Market Debut Despite Supply Crunch
Novo Nordisk A/S (NYSE: NVO) reportedly plans to introduce its highly sought-after anti-obesity medication, Wegovy, in Japan on February 22, marking its inaugural entry into the Asian market despite facing
